Literature DB >> 12225826

Vitrectomy combined with phacoemulsification and intraocular lens implantation for diabetic macular edema.

Kentaro Amino1, Hidenobu Tanihara.   

Abstract

PURPOSE: The outcome of vitrectomy combined with phacoemulsification and intraocular lens implantation (PEA+IOL) for diabetic macular edema was evaluated.
METHODS: Included in this study were 31 patients (42 eyes) with clinically significant diabetic macular edema, in whom posterior vitreous detachment was not observed. Pars plana vitrectomy combined with PEA+IOL was performed on 15 eyes. Sixteen phakic eyes and 11 pseudophakic eyes were followed up without vitrectomy as controls. Visual acuity and the state of macular edema were evaluated.
RESULTS: After follow-up of 18 +/- 7 (mean +/- SD) months, clinically significant macular edema remained in 3 eyes (20%) of the vitrectomy group, in 11 eyes (69%) of the phakic control group, and in 9 eyes (82%) of the pseudophakic control group. The logarithm of the minimal angle of resolution (Log(MAR)) of the best-corrected visual acuity of the vitrectomy group eyes significantly improved from 1.09 +/- 0.27 to 0.80 +/- 0.35 (P <.01), while that of pseudophakic control eyes significantly decreased from 0.59 +/- 0.17 to 0.86 +/- 0.28 (P <.05). The Log(MAR) of phakic control eyes also decreased from 0.82 +/- 0.36 to 0.93 +/- 0.30, but there was no significant difference (P =.19).
CONCLUSION: Vitrectomy combined with PEA+IOL is an effective surgical modality to improve visual acuity in eyes with clinically significant diabetic macular edema.

Entities:  

Mesh:

Year:  2002        PMID: 12225826     DOI: 10.1016/s0021-5155(02)00526-9

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  7 in total

1.  A randomised controlled feasibility trial of vitrectomy versus laser for diabetic macular oedema.

Authors:  D Thomas; C Bunce; C Moorman; D A H Laidlaw
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

2.  Factors predicting outcome of vitrectomy for diabetic macular oedema: results of a prospective study.

Authors:  S P Shah; M Patel; D Thomas; S Aldington; D A H Laidlaw
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

3.  Surgical results of pars plana vitrectomy combined with phacoemulsification.

Authors:  Chong-qing Yang; Jian-ping Tong; Ding-hua Lou
Journal:  J Zhejiang Univ Sci B       Date:  2006-02       Impact factor: 3.066

4.  Combined intravitreal bevacizumab with phacoemulsification in visually significant cataract and visually significant exudative maculopathy.

Authors:  Ahmad Mansour; Ziad F Bashshur; Tarek A Sibai; Abla Mehio-Sibai; Rola N Hamam
Journal:  Oman J Ophthalmol       Date:  2011-01

5.  Surgical results of triamcinolone assisted pars plana vitrectomy combined with phacoemulsification in diabetic patients.

Authors:  Hakki Birinci
Journal:  Open Ophthalmol J       Date:  2008-01-30

6.  Cataracts in diabetic patients: a review article.

Authors:  Mohammad-Ali Javadi; Siamak Zarei-Ghanavati
Journal:  J Ophthalmic Vis Res       Date:  2008-01

Review 7.  Cataract surgery in diabetes mellitus: A systematic review.

Authors:  Aditya Kelkar; Jai Kelkar; Hetal Mehta; Winfried Amoaku
Journal:  Indian J Ophthalmol       Date:  2018-10       Impact factor: 1.848

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.